Bioinformatics Leipzig - Publications

Publications - Supplemental material

Please find below supplemental material corresponding to publications of our group. Currently, we list 132 supplements. If you have problems accessing electronic information, please let us know:

©NOTICE: All documents are copyrighted by the authors; If you would like to use all or a portion of any paper, please contact the author.

This supplement is also available at http://www.bioinf.uni-leipzig.de/publications/supplements/21-002
You may use this URL to cite or link to us.

BIOINF 21-002: Early childhood metabolome can reveal BMI tendency at the age of 8

Stephanie Kehr, Ulrike Rolle-Kampczyk, Stefan Röder, Wolfgang Otto, Gunda Herberth, Ana Zenclussen, Peter F. Stadler, Martin von Bergen

PreProcess

	age0	age1	age2	age3	age4	age8	age10
FA	250	221	49	187	239	-	-
female	119	109	24	93	118	-	-
male	131	109	25	94	118	-	-
BMI_z	0	216	49	181	234	663	559
CV	36.66	37.425	27.18	33.9	27.14	44.49	-
AA	305	92	147	156	144	-	-
female	150	46	64	79	72	-	-
male	155	46	83	76	70	-	-
BMI_z	0	92	145	147	141	482	411
CV	31.8	28.15	28.95	29.32	24.065	39.08	-

Discriminant Analysis

Age PLS-DA

Fatty Acids: - PLS-DA [pdf]; - ROC [pdf]

Amino Acids: - PLS-DA [pdf]; - ROC [pdf]

Metabolite Dynamics

Age Trajectories

Acylcarnitines: - C0: [pdf]; - C2: [pdf]; - C18.1: [pdf]
Sugar: - H1: [pdf]

Lyso-glycerophospholipids: - lysoPC.a.C16.0: [pdf]; - lysoPC.a.C16.1: [pdf]; - lysoPC.a.C17.0: [pdf]; - lysoPC.a.C18.0: [pdf]; - lysoPC.a.C18.1: [pdf]; - lysoPC.a.C18.2: [pdf]; - lysoPC.a.C20.3: [pdf]; - lysoPC.a.C20.4: [pdf]; - lysoPC.a.C24.0: [pdf]; - lysoPC.a.C26.0: [pdf]; - lysoPC.a.C26.1: [pdf]; - lysoPC.a.C28.0: [pdf]; - lysoPC.a.C28.1: [pdf]

Glycerophospholipids diacyl: - PC.aa.C24.0: [pdf]; - PC.aa.C28.1: [pdf]; - PC.aa.C30.0: [pdf]; - PC.aa.C32.0: [pdf]; - PC.aa.C32.1: [pdf]; - PC.aa.C32.2: [pdf]; - PC.aa.C32.3: [pdf]; - PC.aa.C34.1: [pdf]; - PC.aa.C34.2: [pdf]; - PC.aa.C34.3: [pdf]; - PC.aa.C34.4: [pdf]; - PC.aa.C36.0: [pdf]; - PC.aa.C36.1: [pdf]; - PC.aa.C36.2: [pdf]; - PC.aa.C36.3: [pdf]; - PC.aa.C36.4: [pdf]; - PC.aa.C36.5: [pdf]; - PC.aa.C36.6: [pdf]; - PC.aa.C38.0: [pdf]; - PC.aa.C38.1: [pdf]; - PC.aa.C38.3: [pdf]; - PC.aa.C38.4: [pdf]; - PC.aa.C38.5: [pdf]; - PC.aa.C38.6: [pdf]; - PC.aa.C40.2: [pdf]; - PC.aa.C40.3: [pdf]; - PC.aa.C40.4: [pdf]; - PC.aa.C40.5: [pdf]; - PC.aa.C40.6: [pdf]; - PC.aa.C42.0: [pdf]; - PC.aa.C42.1: [pdf]; - PC.aa.C42.2: [pdf]; - PC.aa.C42.4: [pdf]; - PC.aa.C42.5: [pdf]; - PC.aa.C42.6: [pdf]

Glycerophospholipids acyl-alkyl: - PC.ae.C30.0: [pdf]; - PC.ae.C30.1: [pdf]; - PC.ae.C30.2: [pdf]; - PC.ae.C32.1: [pdf]; - PC.ae.C32.2: [pdf]; - PC.ae.C34.0: [pdf]; - PC.ae.C34.1: [pdf]; - PC.ae.C34.2: [pdf]; - PC.ae.C34.3: [pdf]; - PC.ae.C36.0: [pdf]; - PC.ae.C36.1: [pdf]; - PC.ae.C36.2: [pdf]; - PC.ae.C36.3: [pdf]; - PC.ae.C36.4: [pdf]; - PC.ae.C36.5: [pdf]; - PC.ae.C38.0: [pdf]; - PC.ae.C38.1: [pdf]; - PC.ae.C38.2: [pdf]; - PC.ae.C38.3: [pdf]; - PC.ae.C38.4: [pdf]; - PC.ae.C38.5: [pdf]; - PC.ae.C38.6: [pdf]; - PC.ae.C40.1: [pdf]; - PC.ae.C40.2: [pdf]; - PC.ae.C40.3: [pdf]; - PC.ae.C40.4: [pdf]; - PC.ae.C40.5: [pdf]; - PC.ae.C40.6: [pdf]; - PC.ae.C42.1: [pdf]; - PC.ae.C42.2: [pdf]; - PC.ae.C42.3: [pdf]; - PC.ae.C42.4: [pdf]; - PC.ae.C42.5: [pdf]; - PC.ae.C44.3: [pdf]; - PC.ae.C44.4: [pdf]; - PC.ae.C44.5: [pdf]; - PC.ae.C44.6: [pdf]

Sphinglipids: - SM.C16.0: [pdf]; - SM.C16.1: [pdf]; - SM.C18.0: [pdf]; - SM.C18.1: [pdf]; - SM.C20.2: [pdf]; - SM.C22.3: [pdf]; - SM.C24.0: [pdf]; - SM.C24.1: [pdf]; - SM.C26.0: [pdf]; - SM.C26.1: [pdf]; - SM..OH..C14.1: [pdf]; - SM..OH..C16.1: [pdf]; - SM..OH..C22.1: [pdf]; - SM..OH..C22.2: [pdf]; - SM..OH..C24.1: [pdf]

AminoAcids: - Ala: [pdf]; - Arg: [pdf]; - Asn: [pdf]; - Asp: [pdf]; - Cit: [pdf]; - Gln: [pdf]; - Glu: [pdf]; - Gly: [pdf]; - His: [pdf]; - Ile: [pdf]; - Leu: [pdf]; - Lys: [pdf]; - Met: [pdf]; - Orn: [pdf]; - Phe: [pdf]; - Pro: [pdf]; - Ser: [pdf]; - Thr: [pdf]; - Trp: [pdf]; - Tyr: [pdf]; - Val: [pdf]
Biogenic Amines: - AAA: [pdf]; - ADMA: [pdf]; - alpha.AAA: [pdf]; - BCAA: [pdf]; - Creatinine: [pdf]; - Kynurenine: [pdf]; - Sarcosine: [pdf]; - Serotonin: [pdf]

VennDiagrams: - Venn FA: [pdf]; - Venn AA: [pdf]

Correlation Networks

Newborn: [Age0]

Age1: [Age1]

Age2: [Age2]

Age3: [Age3]

Age4: [Age4]

Age1-Age4: [BMI_z-BMI_z8]

Consensus Networks: [Age0-4]; [Age1-4]

Differential Networks: [All to Age0]; [All to Age4]; [Age1-Age3 to Age4]

BMI correlation

Age1: [BMI_z1-BMI_z8]

Age2: [BMI_z2-BMI_z8]

Age3: [BMI_z3-BMI_z8]

Age4: [BMI_z4-BMI_z8]

Age1-Age4: [BMI_z-BMI_z8]

Sublipids sPLS-DA

lysoGlycerophospholipids: [lysoGlycerophospholipids]; [Loadings]

Glycerophospholipids: [Glycerophospholipids]; [Loadings]

PC.aa: [PC.aa]; [Loadings]

PC.ae: [PC.ae]; [Loadings]

Shinglipids: [Sphinglipids]; [Loadings]

Diffential Trajectories Normal and Overweight and Obese

Acylcarnitines: - C0: [pdf]; - C2: [pdf]; - C18.1: [pdf]

Lyso-glycerophospholipids: - lysoPC.a.C16.0: [pdf]; - lysoPC.a.C16.1: [pdf]; - lysoPC.a.C17.0: [pdf]; - lysoPC.a.C18.0: [pdf]; - lysoPC.a.C18.1: [pdf]; - lysoPC.a.C18.2: [pdf]; - lysoPC.a.C20.3: [pdf]; - lysoPC.a.C20.4: [pdf]; - lysoPC.a.C24.0: [pdf]; - lysoPC.a.C26.0: [pdf]; - lysoPC.a.C26.1: [pdf]; - lysoPC.a.C28.0: [pdf]; - lysoPC.a.C28.1: [pdf]

Glycerophospholipids diacyl: - PC.aa.C24.0: [pdf]; - PC.aa.C28.1: [pdf]; - PC.aa.C30.0: [pdf]; - PC.aa.C32.0: [pdf]; - PC.aa.C32.1: [pdf]; - PC.aa.C32.2: [pdf]; - PC.aa.C32.3: [pdf]; - PC.aa.C34.1: [pdf]; - PC.aa.C34.2: [pdf]; - PC.aa.C34.3: [pdf]; - PC.aa.C34.4: [pdf]; - PC.aa.C36.0: [pdf]; - PC.aa.C36.1: [pdf]; - PC.aa.C36.2: [pdf]; - PC.aa.C36.3: [pdf]; - PC.aa.C36.4: [pdf]; - PC.aa.C36.5: [pdf]; - PC.aa.C36.6: [pdf]; - PC.aa.C38.0: [pdf]; - PC.aa.C38.1: [pdf]; - PC.aa.C38.3: [pdf]; - PC.aa.C38.4: [pdf]; - PC.aa.C38.5: [pdf]; - PC.aa.C38.6: [pdf]; - PC.aa.C40.2: [pdf]; - PC.aa.C40.3: [pdf]; - PC.aa.C40.4: [pdf]; - PC.aa.C40.5: [pdf]; - PC.aa.C40.6: [pdf]; - PC.aa.C42.0: [pdf]; - PC.aa.C42.1: [pdf]; - PC.aa.C42.2: [pdf]; - PC.aa.C42.4: [pdf]; - PC.aa.C42.5: [pdf]; - PC.aa.C42.6: [pdf]

Glycerophospholipids acyl-alkyl: - PC.ae.C30.0: [pdf]; - PC.ae.C30.1: [pdf]; - PC.ae.C30.2: [pdf]; - PC.ae.C32.1: [pdf]; - PC.ae.C32.2: [pdf]; - PC.ae.C34.0: [pdf]; - PC.ae.C34.1: [pdf]; - PC.ae.C34.2: [pdf]; - PC.ae.C34.3: [pdf]; - PC.ae.C36.0: [pdf]; - PC.ae.C36.1: [pdf]; - PC.ae.C36.2: [pdf]; - PC.ae.C36.3: [pdf]; - PC.ae.C36.4: [pdf]; - PC.ae.C36.5: [pdf]; - PC.ae.C38.0: [pdf]; - PC.ae.C38.1: [pdf]; - PC.ae.C38.2: [pdf]; - PC.ae.C38.3: [pdf]; - PC.ae.C38.4: [pdf]; - PC.ae.C38.5: [pdf]; - PC.ae.C38.6: [pdf]; - PC.ae.C40.1: [pdf]; - PC.ae.C40.2: [pdf]; - PC.ae.C40.3: [pdf]; - PC.ae.C40.4: [pdf]; - PC.ae.C40.5: [pdf]; - PC.ae.C40.6: [pdf]; - PC.ae.C42.1: [pdf]; - PC.ae.C42.2: [pdf]; - PC.ae.C42.3: [pdf]; - PC.ae.C42.4: [pdf]; - PC.ae.C42.5: [pdf]; - PC.ae.C44.3: [pdf]; - PC.ae.C44.4: [pdf]; - PC.ae.C44.5: [pdf]; - PC.ae.C44.6: [pdf]

Sphinglipids: - SM.C16.0: [pdf]; - SM.C16.1: [pdf]; - SM.C18.0: [pdf]; - SM.C18.1: [pdf]; - SM.C20.2: [pdf]; - SM.C22.3: [pdf]; - SM.C24.0: [pdf]; - SM.C24.1: [pdf]; - SM.C26.0: [pdf]; - SM.C26.1: [pdf]; - SM..OH..C14.1: [pdf]; - SM..OH..C16.1: [pdf]; - SM..OH..C22.1: [pdf]; - SM..OH..C22.2: [pdf]; - SM..OH..C24.1: [pdf]

Sugar: - H1: [pdf]

Cluster Approach

Different Dynamics: - PC.aa.C36.1: [pdf]; - PC.ae.C34.1: [pdf]; - PC.ae.C36.1: [pdf]; - PC.ae.C38.2: [pdf]; - PC.ae.C38.5: [pdf]